.Amgen has actually shared (PDF) the very first phase 3 data on its own $400 thousand eczema drug, c...
.Biogen and also UCB's gamble on advancing into stage 3 on the back of a broken research study hopes...
.Italian biotech Aptadir Therapies has actually introduced with the pledge that its pipe of preclini...
.Surge Life Sciences has actually fulfilled its own target in a Duchenne muscle dystrophy (DMD) stud...
.After a handful of years in biotech, Mike Quigley, Ph.D., is going back to the pharma crease, takin...
.Achilles Therapies has wrecked its technique. The English biotech is quiting working on its clinica...
.Aligos Therapeutics is heralding a midstage gain in metabolic-dysfunction linked steatohepatitis (M...
.Basilea Pharmaceutica's job creating brand new antifungals has acquired a notable boost from the un...
.Having currently scooped up the U.S. civil liberties to Capricor Rehabs' late-stage Duchenne muscle...
.After pushing back the decision date for Applied Therapies' metabolic problem drug govorestat, the ...